Compounds > n-methyl-3,4-methylenedioxyamphetamine
Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Bone Marrow Diseases

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Bone Marrow Diseases in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Bone Marrow Diseases: Diseases involving the BONE MARROW.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nosari, A1
Marbello, L1
De Carlis, LG1
De Gasperi, A1
Muti, G1
Mancini, V1
Morra, E1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Bone Marrow Diseases

ArticleYear
Bone marrow hypoplasia complicating tacrolimus (FK506) therapy.
    International journal of hematology, 2004, Volume: 79, Issue:2

    Topics: Adolescent; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cyclosporine; Female; Huma

2004